Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Aug 21;11(1):2390080.
doi: 10.1080/23320885.2024.2390080. eCollection 2024.

Is capsulectomy necessary for symptom improvement in patients undergoing implant removal for systemic symptoms?

Patricia McGuire  1 , Caroline Glicksman  2
Affiliations
Case Reports

Is capsulectomy necessary for symptom improvement in patients undergoing implant removal for systemic symptoms?

Patricia McGuire et al. Case Reports Plast Surg Hand Surg. .

Abstract

A case of symptom improvement after implant removal without capsulectomy is presented with a review of the literature.

Keywords: Case report; breast implants; capsulectomy.

PubMed Disclaimer

Conflict of interest statement

Dr Glicksman is medical director for the Motiva US FDA Clinical trials. Dr McGuire is a clinical investigator for the Motiva US FDA clinical trials.

Figures

Figure 1.
Figure 1.
The patient before and 1 year after removal of her 300 cc smooth, saline implants.
Figure 2.
Figure 2.
The removed, smooth, intact saline implants.
Figure 3.
Figure 3.
The translucent capsules.
See this image and copyright information in PMC

References

    1. Magnusson MR, Cooter RD, Rakhorst H, et al. . Breast im-plant illness: a way forward. Plast and Reconstr Surg. 2019;143(3S):74S–81S. - PubMed
    1. Breast implant illness. Explant. 2023. Accessed March 20, 2024. https://www.breastimplantillness.com/explant-breast-implant-removal/.
    1. Glicksman C, McGuire P, Ferenz S, et al. . Symptom improvement after explantation with no capsulectomy for systemic symptoms associated with breast implants. Aesthetic Surg J. 2024. doi: 10.1093/asj/sjae034. - DOI - PubMed
    1. Ashar B. CDRH statement: CDRH’s continued commitment to breast implant safety. 2024. Accessed March 23, 2024. https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh....
    1. Glicksman C, McGuire P, Kadin M, et al. . Impact of capsulectomy type on post-explantation systemic symptom improvement: findings from the ASERF systemic symptoms in women-biospecimen analysis study: part 1. Aesthet Surg J. 2022;42(7):809–819. doi: 10.1093/asj/sjab417. - DOI - PMC - PubMed

Publication types

LinkOut - more resources